Intracellular Fenton reaction-based mitochondria-targeted copper( ii )–peptide complex and Asc is developed for cancer cell treatment.
No takes yet. Share an insight, caveat, or question.
Li et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: